Cuesta-Casanovas, Laia
Delgado-Martínez, Jennifer
Cornet-Masana, Josep M.
Carbó, José M.
Banús-Mulet, Antònia
Guijarro, Francesca
Esteve, Jordi
Risueño, Ruth M.
Funding for this research was provided by:
Deutsche José Carreras Leukämie-Stiftung
Fundació la Marató de TV3 (201930-30)
Article History
Received: 21 February 2023
Accepted: 11 May 2023
First Online: 19 May 2023
Declarations
:
: This work was approved by the Ethical Committee of Hospital Clínic (Barcelona, Spain) and Hospital Germans Trias i Pujol (Badalona, Spain). Animal work was approved by the Animal Experimentation Ethics Committee of CMCiB (Badalona, Spain).
: Not applicable.
: RMR is a shareholder of Leukos Biotech. JMCM, JMC, RMR are inventors in patents related to leukemia treatments. The other authors have nothing to declare.